3-OBA Is Not an Antagonist of GPR81
Open Access
- 3 January 2022
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12, 803907
Abstract
3-OBA Is Not an Antagonist of GPR81Keywords
This publication has 8 references indexed in Scilit:
- Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of MetforminBiomolecules, 2021
- Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsisCell Death & Differentiation, 2021
- Lactate Suppresses Macrophage Pro-Inflammatory Response to LPS Stimulation by Inhibition of YAP and NF-κB Activation via GPR81-Mediated SignalingFrontiers in Immunology, 2020
- Lactate released by inflammatory bone marrow neutrophils induces their mobilization via endothelial GPR81 signalingNature Communications, 2020
- Microbiota-Derived Lactate Accelerates Intestinal Stem-Cell-Mediated Epithelial DevelopmentCell Host & Microbe, 2018
- Inhibition of G Protein‐Coupled Receptor 81 (GPR81) Protects Against Ischemic Brain InjuryCNS Neuroscience & Therapeutics, 2014
- International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B)Pharmacological Reviews, 2011
- Biological and Pharmacological Roles of HCA Receptors2011